BELANTAMAB MAFODOTIN for Bone lesion: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 9 adverse event reports in the FDA FAERS database where BELANTAMAB MAFODOTIN was used for Bone lesion.
Most Reported Side Effects for BELANTAMAB MAFODOTIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Keratopathy | 788 | 34.4% | 181 | 79 |
| Visual acuity reduced | 708 | 30.9% | 152 | 65 |
| Death | 499 | 21.8% | 499 | 50 |
| Plasma cell myeloma | 380 | 16.6% | 191 | 61 |
| Dry eye | 359 | 15.7% | 43 | 31 |
| Night blindness | 317 | 13.8% | 24 | 18 |
| Photophobia | 183 | 8.0% | 12 | 12 |
| Foreign body sensation in eyes | 151 | 6.6% | 9 | 10 |
| Vision blurred | 134 | 5.8% | 20 | 17 |
| Ocular toxicity | 94 | 4.1% | 18 | 5 |
| Punctate keratitis | 91 | 4.0% | 16 | 10 |
| Thrombocytopenia | 90 | 3.9% | 39 | 35 |
| Visual impairment | 86 | 3.8% | 9 | 8 |
| Eye disorder | 75 | 3.3% | 11 | 9 |
| Corneal epithelial microcysts | 74 | 3.2% | 9 | 7 |
Other Indications for BELANTAMAB MAFODOTIN
Plasma cell myeloma (1,382)
Product used for unknown indication (786)
Plasma cell myeloma refractory (113)
Disease progression (6)
Amyloidosis (5)
Other Drugs Used for Bone lesion
DENOSUMAB (157)
ZOLEDRONIC ACID (79)
CYCLOPHOSPHAMIDE (18)
DEXAMETHASONE (16)
BORTEZOMIB (13)
LENALIDOMIDE (13)
PAMIDRONATE (10)
POMALIDOMIDE (10)
DARATUMUMAB (9)
ELOTUZUMAB (9)